S&P Global downgrades Hormel Foods outlook on high leverage

S&P Global Ratings revised Hormel Foods' outlook to negative from stable while affirming its A- issuer and debt ratings, citing adjusted leverage of 1.8x as of July 26, 2026, versus its prior expectation of deleveraging toward 1.5x. EBITDA margins have fallen from above 14% pre-COVID to below 11%, pressured by higher pork, beef, nut and logistics costs, while Q3 organic sales declined 2% amid weaker retail consumption. S&P projects leverage near 1.8x in fiscal 2026 before easing to 1.7x in 2027 and 1.6x in 2028; a downgrade is possible if margins, volumes, cost savings, or deleveraging do not improve.

Analysis

The relevant transmission is not a near-term refinancing event but a narrowing of strategic flexibility: subscale asset sales do little to repair leverage while depressed cash conversion makes the dividend, capex, and reinvestment budget compete for the same dollars. That raises the probability that management protects the payout at the expense of brand investment, which would compound volume weakness versus better-funded packaged-food peers. Equity downside can therefore exceed the direct impact of a one-notch credit action, since the market will begin to discount a lower-quality, lower-growth staple rather than a temporary protein-cost issue.

Over the next 1-3 months, the key catalyst is whether gross-margin recovery from lower commodity inputs converts into EBITDA and free cash flow rather than being passed through in lower shelf prices. HRL needs evidence that its restructuring program is producing measurable savings and that branded volumes stabilize; without it, consensus estimates likely retain too much operating leverage to an input-cost normalization. A downgrade would matter most if it coincides with wider consumer-staples credit spreads or a guidance reset, creating a multiple-compression event rather than simply modestly higher interest expense.

The contrarian case is that protein and nut input deflation can restore margins faster than the market expects, while divestitures remove earnings volatility even if proceeds are limited. That thesis is falsified if the next two reported quarters show no sequential improvement in adjusted EBITDA margin, working-capital cash conversion remains weak, or retail volumes continue declining despite easier comparisons. Relative value favors companies with cleaner balance sheets and less commodity-price revenue pass-through, including GIS and CAG; TYSON Foods (TSN) is not a clean hedge because its own protein-cycle exposure is substantially higher.

Key Decisions for Investors

• Maintain an underweight or initiate a 3-6 month short HRL only on a failed post-earnings rally or a break below the pre-earnings low; target 10-15% downside from entry, with a stop if management delivers two consecutive quarters of margin expansion and raises free-cash-flow guidance.
• Pair trade for 3-6 months: long GIS or CAG / short HRL in equal dollar amounts. The thesis is relative margin and balance-sheet resilience, not a broad defensive-sector call; exit if HRL's EBITDA margin closes the gap materially or if branded-volume trends turn positive.
• Monitor HRL bond spreads, debt maturities, and any change in dividend or repurchase policy before expressing a credit trade. A negative outlook alone is insufficient for CDS or bond positioning; initiate only if spreads widen disproportionately to A-rated consumer-staples peers without a corresponding improvement in operating guidance.
• Use the next earnings release as the decision point: add risk only if management quantifies savings realization, demonstrates sequential cash-flow improvement, and confirms demand stabilization. Absent those data, avoid buying an apparent commodity-cost relief rally.